Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Musculoskeletal | Rheumatology
Clinical Trials: Acromegaly
A listing of clinical trials currently looking for volunteers to enroll in Acromegaly studies. Click on the closest city to find more detailed information on a research study in your area.
California
Los Angeles : Cedars-Sinai Medical Center
Ultrasound Guided Sandostatin LAR Injection in Acromegaly
New Jersey
Basking Ridge : Ipsen Updated
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Brazil
Botucatu : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Campinas : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Fortaleza : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Joinville : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Rio de Janeiro : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
View More »
Sao Luis : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
São Paulo : Novartis Investigative Site
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Canada
Montreal : CHUM - Notre-Dame Hospital
Estrogen Treatment in Acromegalic Women
Germany
Berlin : Campus Charité Mitte
Efficacy and Safety of Octreolin for Acromegaly
Hamburg : ENDOC Center for Endocrine Tumors
Efficacy and Safety of Octreolin for Acromegaly
Munich : Max Planck Institute of Psychiatry
Efficacy and Safety of Octreolin for Acromegaly
Munich : Medizinische Klinik Innenstadt
Efficacy and Safety of Octreolin for Acromegaly
Oldenburg : Praxis for Endocrimology and Diabetology in Oldenburg
Efficacy and Safety of Octreolin for Acromegaly
View More »
Wuerzburg : University of Wuerzburg, Department of Endocrinology
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Hungary
Budapest : Semmelweiss University
Efficacy and Safety of Octreolin for Acromegaly
Budapest : Military Hospital, State Health Center 2nd Department of Internal Medicine
Efficacy and Safety of Octreolin for Acromegaly
Pecs : University of Pecs
Efficacy and Safety of Octreolin for Acromegaly
Szeged : University of Szeged
Efficacy and Safety of Octreolin for Acromegaly
Israel
Jerusalem : Hadassah Ein-Karem Medical Center
Efficacy and Safety of Octreolin for Acromegaly
Petach Tikva : Beilinson Hospital
Efficacy and Safety of Octreolin for Acromegaly
Tel Aviv : Tel Aviv Sourasky Medical Center
Efficacy and Safety of Octreolin for Acromegaly
Italy
Japan
Bunkyo-ku : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Kobe : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Maebashi : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Minato-ku : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Nagoya : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
View More »
Shinjuku-ku : Novartis Investigative Site
Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Lithuania
Mexico
Netherlands
Leiden : Leiden University Medical Centre
Efficacy and Safety of Octreolin for Acromegaly
Rotterdam : Erasmus University Medical Center
Efficacy and Safety of Octreolin for Acromegaly
Poland
Katowice : Autonomous Public Clinical Hospital No. 5
Efficacy and Safety of Octreolin for Acromegaly
Poznan : Clinical Hospital of Medical University in Poznan
Efficacy and Safety of Octreolin for Acromegaly
Warsaw : Bielanski Hospital
Efficacy and Safety of Octreolin for Acromegaly
Wroclaw : Wroclaw Medical University
Efficacy and Safety of Octreolin for Acromegaly
Romania
Bucharest : Endocrinology Institute C.I.Parhon
Efficacy and Safety of Octreolin for Acromegaly
Serbia
Slovakia
United Kingdom
